California Prostate Cancer Coalition

Cardiovascular & Metabolic Risk Profiles of Hormonal Agents for Managing Advanced Prostate Cancer http://ow.ly/rwPU50E8n9n

Safety of concomitant therapy with radium-223 and abiraterone or enzalutamide in a real-world population. http://ow.ly/I1eT50E8n7t

Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland - the SAKK 95/16 prostate study. http://ow.ly/VMfW50E8n4i

[18F]DCFPyL PET/CT in Detection and Localization of Recurrent Prostate Cancer Following Prostatectomy Including Low PSA 0.5 ng/mL - Beyond the Abstract http://ow.ly/7AlS50E8n2s

Bone Imaging in Metastatic Prostate Cancer: A Patient Education Video - Ephraim E. Parent http://ow.ly/23Vv50E8mZ2

Questioning the Status Quo: Should Gleason Grade Group 1 Prostate Cancer be Considered A Negative Core in Pre-Radical Prostatectomy Risk Nomograms? An International Multicenter Analysis Beyond the Abstract http://ow.ly/IrK150C0YBm

An Expert Discussion on Gleason 6 (Grade Group 1) Prostate Cancer - Scott Eggener http://ow.ly/694w50C0YxF

Prostate Imaging Quality (PI-QUAL): A New Quality Control Scoring System for Multiparametric Magnetic Resonance Imaging of the Prostate from the PRECISION trial http://ow.ly/ngxG50C0YvK

When and How to Use PARP Inhibitors in Prostate Cancer: A Systematic Review of the Literature with an Update on On-Going Trials http://ow.ly/r0GQ50C0Yuq

Targeting Oligometastasis with Stereotactic Ablative Radiation Therapy or Surgery in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review of Prospective Clinical Trials http://ow.ly/E9vf50C0YsR

Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review http://ow.ly/rpHL50C0Yqx

Does Baseline Serum Testosterone Influence Androgen Deprivation Therapy Outcomes in Hormone Naïve Advanced Prostate Cancer Patients? http://ow.ly/5I5350BUJba

Genetic Risk Factors Identified for Prostate Cancer http://ow.ly/3NGW50BUJ8T

Outcomes of Black men with prostate cancer treated with radiation therapy in the Veterans Health Administration. http://ow.ly/U0MC50BUJ50

Living with Advanced Hormone-Sensitive Prostate Cancer and Treatment with Abiraterone and Androgen Deprivation Therapy: The Patient, Nursing and Physician Perspective. http://ow.ly/j4SE50BUIXf

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. http://ow.ly/5gcn50BUIRJ

Veru Completes Enrollment for Second Part of Phase 1/2 VERU-111 Trial http://ow.ly/8BT950BUIQD

Long View Dialogue - Reshaping cancer control for ageing societies https://www.uicc.org//long-view-dialogue-reshaping-cancer-